Prior authorization required for listed elective OSA surgeries

Prior authorization/medical necessity review is required for the elective surgical procedures listed in this policy (for example, palatopharyngoplasty/UPPP, hyoid suspension, tongue base procedures, hypoglossal nerve stimulator implantation) and site‑of‑service determination must follow the policy's ASC/hospital outpatient/inpatient guidance.

• PA/medical necessity review applies to listed elective OSA surgeries.
• Site‑of‑service determination (ASC vs hospital outpatient/inpatient) must follow the policy guidance included in the document.

Prior authorization should confirm HNS candidate selection criteria

Prior authorization for hypoglossal nerve stimulation should confirm that the candidate meets the selection criteria reflected in trials and device labeling, including age, OSA severity (AHI), central apnea fraction, documented CPAP failure or inability to tolerate CPAP, BMI limits, and favorable anatomic collapse pattern.

• Confirm age meets device/study criteria (adult age bands noted in device labeling and clinical input).
• Confirm moderate–to–severe OSA with limited central apneas (≤25%).
• Confirm documented CPAP failure or inability to tolerate CPAP and BMI within device‑supported range.
• Confirm absence of complete concentric collapse on DISE when required.

Prior authorization for hypoglossal nerve stimulation (device criteria verification)

Prior authorization for hypoglossal nerve stimulation (device implantation) is implied to verify that the patient meets device‑specific labeling and post‑approval selection criteria: age and AHI range, central apnea fraction, CPAP failure/intolerance, BMI within supported limits, and required anatomic assessment.

• Device‑specific AHI ranges (e.g., Inspire expanded to AHI ≥15 and ≤100) and BMI limits (Inspire supplement notes available data up to BMI ≤40) must be documented.
• For Inspire and similar devices, document device name and that patient meets device labeling requirements.

Coding updates may affect prior authorization submissions

Coding updates and additions (new CPT/HCPCS temporary and permanent codes) noted in the policy history may affect prior authorization processing and required billing codes for HNS and other procedures; verify current codes when submitting authorization requests.

• Recent additions/removals include HCPCS codes (e.g., C1607 added then removed; C8007–C8013 added 04/01/26) and temporary CPT codes (0978T–0980T).
• Use the policy's coding section and history to determine which codes to include with PA requests.

Document failed adequate CPAP or oral appliance trial before surgery

Patients must have failed an adequate trial of CPAP or an oral appliance (when applicable) prior to consideration of the listed surgical treatments; documentation of that failed trial should be included with the authorization request.

• For surgical options such as UPPP, hyoid suspension, tongue or maxillofacial surgery, document prior adequate CPAP or oral appliance trial.
• For HNS, CPAP failure or intolerance must be documented per device labeling (e.g., residual AHI thresholds or insufficient usage).

Conservative therapy (including PAP) must be attempted and documented

Conservative therapy, including attempted and documented PAP (CPAP/BiPAP) therapy, should be tried and recorded prior to considering minimally invasive surgical options; HNS is indicated for those who have failed or cannot tolerate PAP.

• Record conservative management attempts (weight loss, positional therapy, PAP usage) in the medical record prior to PA submission.
• HNS candidacy requires documented failure or intolerance to PAP per device criteria.

PAP is expected as first‑line (step therapy) before device/surgery

The policy references PAP (CPAP/BiPAP) as the most efficacious initial therapy; many device and surgical indications require prior failure, intolerance, or ineligibility for PAP before proceeding to device or surgical options.

• Expect authorization reviewers to require documentation of prior PAP therapy and reasons for failure/intolerance.
• PAP is the default first‑line therapy; surgical or device therapy is considered when PAP is not effective or tolerated.

Document PAP trial/tolerance and outcomes

Document PAP usage, tolerance, and outcomes: prior policy language required PAP tolerance or contraindication for higher AHI ranges and a PAP trial may still be required for authorization decisions — include objective PAP usage data or a statement of contraindication/intolerance.

• Include objective PAP adherence data (hours/night, nights/week) or documentation of residual AHI while on PAP when claiming PAP failure.
• If PAP is contraindicated or not tolerated, document the clinical reason and attempts at optimization.

Required documentation for surgical OSA procedures

Medical records submitted for review must document clinically significant OSA (AHI/RDI per policy thresholds) and, when applicable, failure or intolerance of nasal CPAP or an oral appliance; for HNS include device name, DISE findings, and the absence of complete concentric collapse.

• For all surgical OSA procedures, include AHI/RDI results supporting clinically significant OSA (see policy thresholds).
• For HNS, include age, AHI, percent central apneas, CPAP failure/intolerance details, BMI, device name, and DISE findings (absence of complete concentric collapse).

Document age, AHI, CPAP failure, BMI, and palatal collapse pattern

Clinical documentation should support patient selection consistent with clinical study populations and device labeling: record patient age, OSA severity (AHI), documented CPAP failure/intolerance, BMI within supported limits, and pattern of palatal collapse (e.g., non‑concentric) when relevant.

• Record age and whether patient falls within device/study age bands (e.g., adult age thresholds or adolescent Down syndrome cohorts).
• Record BMI and ensure it falls within the range supported by safety/effectiveness data (policy notes BMI updates for Inspire).
• When applicable, document DISE findings including absence of complete concentric collapse.

Provide additional documentation for lower‑range AHI (5–15)

When AHI is in the lower ranges (e.g., AHI 5–15), include additional supporting documentation of comorbid conditions or objective measures (for example: stroke, hypertension, ischemic heart disease, excessive daytime sleepiness measures like ESS >10, MSLT <6, frequent desaturations, or BMI >35) as historically required by the policy.

• Provide evidence of relevant comorbidities or objective daytime sleepiness measures when lower‑range AHI is used to justify intervention.
• If AHI is 5–15, include documentation per the policy's historical requirements to support medical necessity.

Document failed CPAP or oral appliance trial before surgical options

Before considering listed surgical treatments, document that the patient has failed an adequate trial of CPAP or an oral appliance (when applicable); for HNS, the policy requires documented CPAP failure (e.g., residual AHI thresholds or insufficient adherence) or inability to tolerate CPAP.

• For HNS, CPAP failure definitions include residual AHI ≥15 despite PAP or insufficient usage (e.g., <4 hrs/night ≥5 nights/week) as specified in device labeling and policy.
• Include objective PAP adherence and efficacy data in the submission.

Document conservative therapy attempts (including CPAP) before minimally invasive procedures

Conservative therapy including PAP should be attempted and documented prior to minimally invasive options; HNS is intended for patients who have failed or cannot tolerate PAP, and documentation of prior conservative management is expected.

• Document nonoperative measures (behavioral/medical) and PAP trial attempts before PA for minimally invasive procedures.
• Explicitly document reasons PAP could not be used or was ineffective when claiming ineligibility.

Step‑therapy expectation: PAP required before device/surgery in most cases

Expect step‑therapy: PAP (CPAP/BiPAP) is referenced as the most efficacious initial therapy and many device indications (including HNS) require prior documented failure, intolerance, or ineligibility for PAP before approving device or surgical interventions.

• Authorization reviewers will look for documented optimization attempts and objective PAP adherence/response.
• If PAP was not attempted, provide justification for PAP ineligibility or contraindication.

Document PAP tolerance/trial and outcomes for authorization

Document PAP tolerance and trial results: historical policy language required PAP tolerance or contraindication for higher AHI ranges and a PAP trial may still influence authorization decisions — provide objective adherence data or clear documentation of intolerance/contraindication.

• Include PAP usage metrics (hours/night, nights/week) or measured residual AHI while on PAP to support claims of PAP failure.
• If PAP is intolerable or contraindicated, document clinical reasoning and attempts to optimize therapy.

High denial risk: procedures for snoring alone and listed investigational procedures

Surgeries performed solely for snoring without documented OSA are considered not medically necessary and are at high risk for denial; minimally invasive procedures listed as investigational (e.g., LAUP, palatal stiffening, RF reduction) are also likely to be denied as not medically necessary or investigational.

• Do not submit authorization requests for procedures intended to treat snoring alone without objective evidence of OSA.
• Expect denial for minimally invasive procedures designated investigational in the policy (including submucosal cryolysis and listed palatal procedures).